secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2023-11-20T23:59:59+00:00
Accession:  0001493152-23-041982
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics announces registered direct offering of 1.14M shares at $0.64/share, with warrants
--------------------------------------------------------------------------------

- Gross proceeds ~$729,200; net proceeds ~$591,000 after fees.
- Warrants to purchase up to 1,139,063 shares at $0.52/exercise, 5.5-year term.
- H.C. Wainwright acts as placement agent; fees: 7% cash, 1% mgmt, 68,344 warrants.
- Closing expected Nov 20, 2023; proceeds for clinical trials, patent portfolio, working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315223041982/0001493152-23-041982-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315223041982/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-041982

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer